Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aptinyx Pulls Back From Neuropsychiatry After Mid-Stage PD Failure
Prioritizes Cutting Costs
Mar 01 2023
•
By
Ayisha Sharma
The Parkinson's Failure Is The Fourth Clinical Setback In Recent Years • Source: Shutterstock
More from Clinical Trials
More from R&D